ClinConnect ClinConnect Logo
Search / Trial NCT06594029

Community Navigators

Launched by TEMPLE UNIVERSITY · Sep 10, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Peer Support Community Participation Serious Mental Illness

ClinConnect Summary

The Community Navigators trial is a study aimed at helping adults with serious mental health issues, such as schizophrenia, bipolar disorder, or major depression, who may feel lonely or socially isolated. The researchers at Temple University are testing a program that connects participants with community navigators—people who can guide them to resources and support in their community. This study will help determine if this approach is effective and how it can benefit individuals dealing with mental health challenges.

To be eligible for this study, participants must be at least 18 years old, speak and understand English, and have a diagnosed serious mental illness. They should also live in a place where they can come and go freely. If someone is unable to give consent themselves, like if they have a legal guardian, they won't be able to participate. Although the study is not recruiting participants yet, those who join can expect to receive support and resources to improve their social connections and overall mental well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. meet the criteria for an SMI diagnosis of schizophrenia, schizoaffective, bipolar, or major depression diagnosis based on the MINI,
  • 2. are over the age of 18-years-old
  • 3. are fluent in English: As current intervention materials and research and intervention personnel are only fluent in English, only participants who can communicate in written and spoken English are eligible for enrollment.
  • 4. have a permanent residence without constraints on participation (free to come and go from residence without restrictions) 2
  • 5. have the ability to provide informed consent.
  • Exclusion Criteria:
  • inability to provide consent (legal guardian)
  • unable to speak and understand English

About Temple University

Temple University is a leading academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to research and innovation in the health sciences. As a clinical trial sponsor, Temple University leverages its extensive resources, including a diverse pool of participants and cutting-edge facilities, to advance medical knowledge and improve patient care. The university's clinical research initiatives are driven by a multidisciplinary team of experts dedicated to conducting high-quality studies that address critical health issues and contribute to the development of novel therapies. Through its partnerships with local and global organizations, Temple University aims to enhance the translation of research findings into practical applications that benefit communities and advance public health.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported